Ro Overview
- Year Founded
-
2017
- Status
-
Private
- Employees
-
831
- Latest Deal Type
-
Debt
- Latest Deal Amount
-
$30M
- Investors
-
82
Ro General Information
Description
Operator of a direct-to-consumer telehealth platform intended to handle everything from diagnosis to convenient medication delivery. The company's platform allows people to get in touch with physicians and has end-to-end services, some for erectile dysfunction and others to help people quit smoking, enabling users to get access to free medication delivery and personalized treatment.
Contact Information
Website
www.ro.coCorporate Office
- 625 6th Avenue
- 4th Floor
- New York, NY 10011
- United States
Corporate Office
- 625 6th Avenue
- 4th Floor
- New York, NY 10011
- United States
Ro Timeline
Ro Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 10. Debt - General | 01-Jul-2024 | $30M | Completed | Generating Revenue | ||
| 9. Accelerator/Incubator | Completed | Generating Revenue | ||||
| 8. Later Stage VC | Completed | Generating Revenue | ||||
| 7. Later Stage VC (Series D1) | 13-Jan-2022 | Completed | Generating Revenue | |||
| 6. Later Stage VC (Series D) | 23-Mar-2021 | Completed | Generating Revenue | |||
| 5. Later Stage VC (Series C) | 24-Jul-2020 | Completed | Generating Revenue | |||
| 4. Early Stage VC (Series B) | 16-Apr-2019 | Completed | Generating Revenue | |||
| 3. Early Stage VC (Series A) | 17-Sep-2018 | Completed | Generating Revenue | |||
| 2. Seed Round | 01-May-2018 | $3.1M | Completed | Generating Revenue | ||
| 1. Seed Round | 31-Oct-2017 | $3.1M | $3.1M | Completed | Generating Revenue |
Ro Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate ($) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series D1 | ||||||||
| Series D | ||||||||
| Series C3 | ||||||||
| Series C2 | ||||||||
| Series C1 | ||||||||
| Series B | ||||||||
| Series A2 | ||||||||
| Series A1 | ||||||||
| Series A | 44,199,290 | $0.000010 | $0.03 | $0.45 | $0.45 | 1x | $0.45 | 10.26% |
| Seed | 31,825,040 | $0.000010 | $0.01 | $0.1 | $0.1 | 1x | $0.1 | 7.39% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
Ro Comparisons
Industry
Financing
Details
Ro Competitors (35)
One of Ro’s 35 competitors is Musely, a Venture Capital-Backed company based in Santa Clara, CA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Musely | Venture Capital-Backed | Santa Clara, CA | ||||
| HealthTap | Venture Capital-Backed | Sunnyvale, CA | ||||
| Kry | Venture Capital-Backed | Stockholm, Sweden | ||||
| Halodoc | Venture Capital-Backed | Jakarta Selatan, Indonesia | ||||
| Healthera | Venture Capital-Backed | Cambridge, United Kingdom |
Ro Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
News about Ro
Dive into recent articles by PitchBook offering invaluable insights and context.
-
NEWS | Oct 24, 2024
General Catalyst's $8B haul cements return of mega-funds
General Catalyst has raised $6 billion for its Fund XII and an additional $2B for separately managed accounts for select LPs
-
NEWS | Apr 29, 2024
IPO Watchlist: The digital health unicorns most likely to go public
Late-stage funding for digital health has fallen off, but investors can still expect to see at least three successful IPOs in 2024.
Ro Patents
Ro Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-11478228-B2 | System and method for bodily fluid capture and preservation | Active | 20-Nov-2018 | ||
| US-20200261315-A1 | System and method for bodily fluid capture and preservation | Active | 20-Nov-2018 | ||
| US-20200155126-A1 | System and method for bodily fluid capture and preservation | Active | 20-Nov-2018 | ||
| US-11707407-B2 | System and method for bodily fluid capture and preservation | Active | 20-Nov-2018 | ||
| US-11666540-B2 | Individually-packaged wipes for enhancing sexual intercourse | Active | 28-Jan-2014 | A61K9/7007 |
Ro Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Ro Investors (82)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Ambush Capital | Angel Group | Minority | ||
| B&Y Venture Partners | Venture Capital | Minority | ||
| Designer Fund | Venture Capital | Minority | ||
| KBW Ventures | Venture Capital | Minority | ||
| Leonis Capital | Venture Capital | Minority |
Ro Acquisitions (6)
Ro’s most recent deal was a Merger/Acquisition with Dadi for . The deal was made on 01-Mar-2022.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Dadi | 01-Mar-2022 | Merger/Acquisition | Other Devices and Supplies | ||
| Kit.com | 30-Jun-2021 | Merger/Acquisition | Laboratory Services (Healthcare) | ||
| Modern Fertility | 19-May-2021 | Merger/Acquisition | Other Devices and Supplies | ||
| Preboost | 09-Dec-2020 | Merger/Acquisition | Medical Supplies | ||
| Workpath | 08-Dec-2020 | Merger/Acquisition | Enterprise Systems (Healthcare) |
Ro Affiliates
Subsidiaries (1)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| Arabella | New York, NY | 2011 |
Ro FAQs
-
When was Ro founded?
Ro was founded in 2017.
-
Where is Ro headquartered?
Ro is headquartered in New York, NY.
-
What is the size of Ro?
Ro has 831 total employees.
-
What industry is Ro in?
Ro’s primary industry is Clinics/Outpatient Services.
-
Is Ro a private or public company?
Ro is a Private company.
-
What is Ro’s current revenue?
The current revenue for Ro is .
-
How much funding has Ro raised over time?
Ro has raised $1.06B.
-
Who are Ro’s investors?
Ambush Capital, B&Y Venture Partners, Designer Fund, KBW Ventures, and Leonis Capital are 5 of 82 investors who have invested in Ro.
-
Who are Ro’s competitors?
Musely, HealthTap, Kry, Halodoc, and Healthera are some of the 35 competitors of Ro.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
